St. Jude Expects Epic HF CRT Approval By May 2004 NASPE/HRS Meeting
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical is lowering average selling prices for its U.S. ICDs and pacemakers by roughly 5% to counter Guidant and Medtronic's strategy of "bundling" cardiac resynchronization therapy defibrillators (CRT-D) with traditional ICDs and pacemakers